TIOCONAZOLE

Manufacturer: DPT Laboratories, Ltd.
Effective date: 2009-08-31
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 22:22:33

Label at a glance#

ProductTIOCONAZOLE Ointment 6.5%

Active ingredientTIOCONAZOLE

Label structure13 sections

Dosage and administration

before using this product read the enclosed brochure and instructions on foil packet for complete directions and information adults and children 12 years and over: 1.Open the foil packet just before use and remove purple cap. 2.Insert entire contents of applicator into the vagina at bedtime. Throw applicator away after use. children under 12 years of age: ask a doctor

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient
(i n each applicator)
Tioconazole 300 mg (6.5%)

Purpose
vaginal antifungal

Use

OTC - PURPOSE SECTION

treats vaginal yeast infections

Warnings

WARNINGS SECTION

For vaginal use only

OTC - DO NOT USE SECTION

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

vaginal itching and discomfort for the first time
lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition.
vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system.
been exposed to human immunodeficiency virus (HIV) that causes AIDS

When using this product

OTC - WHEN USING SECTION

do not use tampons, douches, spermicides, or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted disease (STDs).
do not have vaginal intercourse
mild increase in vaginal burning, itching or irritation may occur

Stop use and ask a doctor if

OTC - STOP USE SECTION

symptoms do not get better after 3 days
symptoms last more than 7 days
you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

INDICATIONS & USAGE SECTION

before using this product read the enclosed brochure and instructions on foil packet for complete directions and information
adults and children 12 years and over: 1.Open the foil packet just before use and remove purple cap. 2.Insert entire contents of applicator into the vagina at bedtime. Throw applicator away after use.
children under 12 years of age: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

this product is a 1-dose treatment, most women do not experience complete relief of their symptoms in just one day. Most women experience some relief within one day and complete relief of symptoms within 7 days.
if you have questions about vaginal yeast infections, consult your doctor
store at 20 - 25°C (68 - 77°F)
see end flap of carton for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

butylated hydroxyanisole, magnesium aluminum silicate, white petrolatum

INDICATIONS & USAGE SECTION

Do not use if sealed foil packet torn, open, or incompletely sealed.

1-DOSE TREATMENT
TIOCONAZOLE OINTMENT 6.5%
VAGINAL ANTIFUNGAL

DIRECTIONS FOR USE

Tear open foil packet just before using. It is best to use at bedtime.
Remove applicator and plunger from packet. Applicator is prefilled with vaginal ointment.
While firmly holding the purple-capped end of the applicator, push the tip of the plunger into the base of applicator.

REMOVE PURPLE CAP from top of applicator with a pull-twist action.

Insert the applicator

Lie on your back with your knees bent. Gently insert applicator into the vagina as far as it will go comfortably.
Push the plunger into the applicator until it will go no farther. Withdraw the applicator and plunger and dispose of it in the wastebasket. Do not flush.
DO NOT USE TAMPONS while using this medicine. Use sanitary napkins instead.

PLEASE READ EDUCATIONAL BROCHURE FOR ADDITIONAL INFORMATION.

4260000 P6

DISTRIBUTED BY
PERRIGO
ALLEGAN, MI 48010 U.S.A.

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
198380	tioconazole 6.5 % Vaginal Ointment	PSN	1
198380	tioconazole 0.065 MG/MG Vaginal Ointment	SCD	1
198380	tioconazole 6.5 % Vaginal Ointment	SY	1

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
TIOCONAZOLE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63094-0426-1	2019-10-21	C162847	48780-1	956f9ecf-db54-621f-e053-dbdaa90a74ad	11ddf219-8537-4a8f-b267-ef965159885e

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63094-0426-1	TIOCONAZOLEOintment 6.5%	5 g in 1 APPLICATOR	OINTMENT	5		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63094-0426	TIOCONAZOLE OINTMENT 6.5% (TIOCONAZOLE) OINTMENT [DPT LABORATORIES, LTD. ]	1	Legacy NDC, 1 package rows	20090901_11ddf219-8537-4a8f-b267-ef965159885e.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
TIOCONAZOLE	ACTIVE INGREDIENT	S57Y5X1117	1
TIOCONAZOLE	ACTIVE MOIETY	S57Y5X1117	1
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	1
MAGNESIUM ALUMINUM SILICATE	INACTIVE INGREDIENT	6M3P64V0NC	1
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

TIOCONAZOLE Ointment 6.5%
TIOCONAZOLE
BUTYLATED HYDROXYANISOLE
MAGNESIUM ALUMINUM SILICATE
PETROLATUM

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
63094-0426	63094-0426-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TIOCONAZOLE	S57Y5X1117	ACTIB
BUTYLATED HYDROXYANISOLE	REK4960K2U	IACT
MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	IACT
PETROLATUM	4T6H12BN9U	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 59 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / AURICULAR (OTIC)	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	LOTION / TOPICAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUPPOSITORY / VAGINAL	1 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	OINTMENT / VAGINAL		231 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	EMULSION / TOPICAL	7.8 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, FILM COATED / ORAL	0.4 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	SUSPENSION / ORAL	5000 mg/5ml		Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	CREAM / TOPICAL	3 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	AEROSOL, FOAM / TOPICAL	7.9 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	SUSPENSION / RECTAL		14480 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CREAM / TOPICAL		4213 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	SUSPENSION/ DROPS / ORAL	4.15 mg/2.5ml		Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	OINTMENT / VAGINAL	0.02 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	TABLET / ORAL	3.5 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CAPSULE, LIQUID FILLED / ORAL		4 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	GEL / TOPICAL		7 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUSPENSION / ORAL	2.5 mg/5ml		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 17 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CAPSULE, EXTENDED RELEASE / ORAL	0.07 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	TABLET / ORAL	60 mg		Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	LOTION / TOPICAL	1.5 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SOLUTION / ORAL		5 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET / SUBLINGUAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	GRANULE, FOR SUSPENSION / ORAL	12.5 mg/5ml		Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	OINTMENT / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SYRUP / ORAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CONCENTRATE / ORAL	0.08 mg/1ml		Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	SUPPOSITORY / RECTAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	FILM / SUBLINGUAL	0.08 mg		Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET / ORAL		8 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / VAGINAL		4084 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	SOAP / TOPICAL	0.85 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CREAM, AUGMENTED / TOPICAL	26 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	TABLET, EXTENDED RELEASE / ORAL		70 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT, AUGMENTED / TOPICAL	81.94 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	GRANULE, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	SHAMPOO / TOPICAL	1.25 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	LIQUID / ORAL	82 mg/5ml		Exact identifier — unii candidate 17 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	CAPSULE / VAGINAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	TABLET, CHEWABLE / ORAL	12 mg		Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, EXTENDED RELEASE / ORAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	LOTION / TOPICAL	25 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	CAPSULE / ORAL		60 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	CONCENTRATE / ORAL	410 mg/5ml		Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CAPSULE / ORAL		4 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	SUPPOSITORY / VAGINAL	27 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / TOPICAL		7275 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CREAM / TOPICAL		2 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	TABLET, EXTENDED RELEASE / ORAL	0.18 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	LIQUID / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
PETROLATUM	PETROLATUM	4T6H12BN9U	OINTMENT / OPHTHALMIC	88.4 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	SYRUP / ORAL	100 mg/1ml		Exact identifier — unii candidate 17 equally ranked IID candidates
BUTYLATED HYDROXYANISOLE	BUTYLATED HYDROXYANISOLE	REK4960K2U	CREAM / VAGINAL	0.03 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM ALUMINUM SILICATE	MAGNESIUM ALUMINUM SILICATE	6M3P64V0NC	PASTE, DENTIFRICE / DENTAL	0.4 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075915-001	TIOCONAZOLE	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL			2001-11-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075915-001	TIOCONAZOLE	6.5%	OINTMENT / VAGINAL	2001-11-21	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
11ddf219-8537-4a8f-b267-ef965159885e			11ddf219-8537-4a8f-b267-ef965159885e	2009-08-31	Warnings	Exact identifier spl id: 11ddf219-8537-4a8f-b267-ef965159885e spl set id: 11ddf219-8537-4a8f-b267-ef965159885e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.